On Friday's #BiotechHangout, Rob Perez joins @DaphneZohar & @JSchimmer_E to discuss the week's deals, data & FDA actions w/ guests Alex Harding & DiCE CEO Kevin Judice. Tell us if there's a topic you'd like us to cover below & tune in at 3pm ET! x.com/i/spaces/1MYGN…

We are hosting a free spin class at SpinÉnergie on 3483 Parc Avenue November 18th. Spaces are limited so please sign up asap to secure your spot! Following the class, we will have snacks and drinks from 7:45 to 9:30, we can't wait to see you there🚴‍♂️🎉 forms.gle/yWo7MXo6E99vdD…

Come attend the 1st Technical Seminar Series of the academic year! This seminar will focus on explaining the fundamentals of flow cytometry, its applications to different research areas, and tips for setting up a successful flow experiment. We look forward to seeing you!

Come attend the 2nd Technical Seminar Series of the academic year on Thursday December 15th from 10AM to 11AM! Dr. Ruben Lopez Salazar will be presenting “Lipid-based Nanoparticles: The Small Secret Behind Next-generation Vaccines and their Applications in Cancer Research”.

Reminder that abstracts for the 23rd AMBGC are due next Monday, Feb 13 at 11:59. NEW! A cocktail hour will follow after the conference. Stay with us after the awards ceremony to celebrate your accomplishments with your peers. The cocktail hour is included with free registration

I am at that point in my PhD where I skim through signalling pathways in-between reps at the gym 😂 #phdchat #phdlife #AcademicChatter #AcademicTwitter

On #BiotechHangout today Daphne Zohar Brad Loncar Tim Opler michal preminger & Brian Skorney cover latest on $AMGN/ $HZNP and FTC lawsuit, $TSHA financing, $SNY loses $RETA to $BIIB, data & regulatory updates from $SGEN, $PFE, $DCTH, $GLTO & $TSVT, plus $IPSEY gets FDA approval of

BREAKING NEWS The 2023 #NobelPrize in Physiology or Medicine has been awarded to Katalin Karikó and Drew Weissman for their discoveries concerning nucleoside base modifications that enabled the development of effective mRNA vaccines against COVID-19.

x.com/i/spaces/1BRKj…

Excited to have discussed novel vulnerabilities in melanoma at the Canadian Cancer Research Conference. #CCRC23

8 REASONS GLP-1 WILL NOT DISPLACE MASH/NASH 1️⃣GLP-1s not the medicine of choice amongst hepatologists 2️⃣10-15% of MASH pts come in on GLP-1s 3️⃣Will use resmetirom if approved in March $MDGL 4️⃣Sarcopenia with GLP-1s is a particular concern for MASH 5️⃣KOLs not comfortable

The UK Medicines and Healthcare products Regulatory Agency approves the CRISPR/Cas9 gene-edited treatment for #SickleCellDisease & #BetaThalassemia in Great Britain. This is a historic milestone arising out of our collaboration with Vertex. Learn more: crisprtx.com

Nice report coming out later today from @stifel: “Bullish on Biotech” despite continued negative sentiment. They cite 7 fundamental positives including past performance ($NBI & $XBI tripled following past downturns). Sentiment can turn quickly. Bruce Booth’s review & #BioTwitter

On #BiotechHangout today Daphne Zohar, Brad Loncar, John Maraganore 🇺🇸🇬🇷🇺🇦🇮🇱, josh schimmer, Bruce Booth & Yaron Werber cover $ABBV / $IMGN $10B acquisition, FDA’s CAR-T safety concerns, data setbacks & wins ( $ROIV, $ARGX, $XENE, & $IVMT), $REGN & $SNY seek to expand Dupixent approval to COPD,

A huge win in the hemoglobinopathy space. I hope this therapy will afford and assessable in Africa where sickle cell disease is most prevalent.

Right….

💯

Congratulations Dr. Bolu Ogunyemi MD

A huge leap for gene editing therapy

The McGill University Department of Oncology and the Lady Davis Institute for Medical Research (Lady Davis Institute) in Montreal, Canada, are looking for a full-time Assistant Professor (Research) in the area of Fundamental Cancer Biology. ladydavis.ca/en/researchers… #academicstaff #research